TCTAP 2026 Sponsors

Hanmi Pharmaceutical Co., Ltd.

Logo
- RnD-centric Biopharmaceutical Company
Hanmi Pharmaceutical is a representative Korean RnD-centric biopharmaceutical company established in 1973 by pharmacist Sung-ki Lim. We plow ahead in pursuing innovation based on our founders conviction as represented by his words, Lets use our technology to make better medicines and his management philosophy of Respect for humanity and Value Creation.
_1st_Highest Number of Open Innovation Achievements Highest Number of Independently Developed Innovative Products among Korean Biopharmaceutical Companies.
_26+_Highest Number of Breakthrough New Drug Pipelines in Korea
_4.5Trillion won_Cumulative RnD Investment
_ AAA in CP Rating_First and Only among participating companies in Korea

- Hanmi is a Pioneer
No path started as a path. Today Hanmi became the protagonist in the development history of the Korean biopharmaceutical industry.
First, Most, and Largest are the indicators that compress the key performance of Hanmi, overwhelming the indutry.

Satellite Symposium

Lunchtime Activities

A Paradigm Shift in Dyslipidemia Treatment

Organized by CVRF and Supported by Educational Grant From Hanmi Pharmaceutical Co., Ltd.

Thursday, April 30
12:20 PM ~ 1:20 PM * KST (UTC/GMT +9:00)
Room 209, Level 2
Moderator(s): Yunseok Choi, Jung-Sun Kim
12:20 PM Beyond the Statin, ROSUZET; Start Early, Switch Now
Lecturer: Gyu Chul Oh
12:50 PM Discussion
AI Translations icon AI Translations

Lunchtime Activities

A New Paradigm for Initial Treatment of Hypertension

Organized by CVRF and Supported by Educational Grant From Hanmi Pharmaceutical Co., Ltd.

Saturday, May 2
12:20 PM ~ 1:20 PM * KST (UTC/GMT +9:00)
Presentation Theater 2, Level 1
Moderator(s): Jin Bae Lee, Wook Bum Pyun
12:20 PM Which Patients Benefit From Ultra–Low-Dose Triple Fixed-Dose Combination Therapy?
Lecturer: Jong-Young Lee
12:50 PM Discussion